Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome (Q42441283)

31 October 2017

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

31 October 2017

1 reference

1 reference

3

1 reference

31 October 2017

1

Ricardo Azziz

1 reference

31 October 2017

David A Ehrmann

2

1 reference

31 October 2017

Anita G Fereshetian

4

1 reference

31 October 2017

Mary O'Keefe

5

1 reference

31 October 2017

Mahmoud N Ghazzi

6

1 reference

31 October 2017

PCOS/Troglitazone Study Group

7

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

31 October 2017

Fertility and Sterility

1 reference

31 October 2017

79

1 reference

31 October 2017

4

1 reference

31 October 2017

932-937

1 reference

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Adrenal androgen excess in hyperandrogenism: relation to age and body mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Suppression of Circulating Δ4-Androstenedione and Dehydroepiandrosterone Sulfate during Oral Glucose Tolerance Test in Normal Females*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Effect of Acute Physiological Elevations of Insulin on Circulating Androgen Levels in Nonobese Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Androgen and insulin response to an oral glucose challenge in hyperandrogenic women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Elevated serum dehydroepiandrosterone sulfate levels in patients with insulin resistance, hirsutism, and acanthosis nigricans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Adrenal steroidogenesis is related to insulin in hyperandrogenic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3β-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Mechanisms of insulin inhibition of ACTH-stimulated steroid secretion by cultured bovine adrenocortical cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

The Effects of Prolonged Hypertestosteronemia on Adrenocortical Biosynthesis in Oophorectomized Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904914-2

10.1016/S0015-0282(02)04914-2

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference